Aclaris Therapeutics
ACRS
ACRS
34 hedge funds and large institutions have $276M invested in Aclaris Therapeutics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% less capital invested
Capital invested by funds: $277M → $276M (-$1.25M)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.2M | |
| 2 | +$556K | |
| 3 | +$534K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$366K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$341K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$293K | |
| 3 | -$156K | |
| 4 |
EEG
E.E. Geduld
|
-$42.2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$28K |